Corporate News

3 March 2023

Discover Our New Fluorescent Ligands For C5a Receptor

Our portfolio of #GPCR#fluorescent ligands is growingWe have just added to our catalogue more fluorescent ligands for the C5a receptor, CELT-58 and CELT-68. The C5a anaphylatoxin chemotactic receptor 1 (C5aR, also […]
19 December 2022

Celtarys Research has signed a strategic research cooperation agreement with the European platform EU-OPENSCREEN

We are glad to announce that Celtarys Research has reached a strategic research cooperation agreement with the European platform EU-OPENSCREEN ( ), a not-for-profit European Research Infrastructure […]
9 November 2022

Celtarys Research, sponsor of the XIV Meeting of the Spanish Drug Discovery Network

The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Granada, Spain, on November 24 and 25, 2022. This international conference has […]
20 September 2022

Fluorescent ligands: A New Method to Label your GPCRs

To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
26 July 2022

Celtarys Adenosine Receptor fluorescent ligands as potent tools for the study of cancer specific GPCRs

The ONCOMET group from the Health Research Institute of Santiago led by Dr. Miguel Abal has published an interesting article showing tumor and stromal-specific genetic signatures […]
15 July 2022

Celtarys Research and Chemspace sign a distribution agreement for the commercialization of Celtarys products

We are proud to announce our new collaboration with the marketplace company Chemspace for the distribution of our exclusive GPCR fluorescent probes. Chemspace is the largest […]
6 April 2022

New GLP1 Receptor fluorescent probes LUXendins developed by our collaborators Johannes Broichhagen and David J. Hodson

The glucagon-like peptide-1 receptor (GLP1R), expressed in peripheral tissues and brain, is known to be involved in several metabolic and inflammatory processes. Despite its clear interest […]
3 February 2022

Celtarys Research Adenosine A3 Receptor fluorescent ligand as a new tool for the study of non-orthosteric interactions

The group led by Dr. Eddy Sotelo at the University of Santiago de Compostela, in collaboration with the Uppsala University, has published a new article exploring […]
28 December 2021

Celtarys exclusive fluorescent ligands for cannabinoid receptors used to analyze binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Don’t miss the new article by Dr. Gemma Navarro and Dr. Rafael Franco about cannabinoid CB1 and CB2 receptors signaling. They have successfully used CELT-335, one […]